Mounting clinical evidence could lead to the approval of new psychedelic medicines. The FDA’s draft guidance on psychedelics research includes several recommendations that may be contentious.
No takes yet. Share an insight, caveat, or question.
Marks et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: